Sintilimab Plus Bevacizumab in Recurrent/Persistent Ovarian Clear Cell Carcinoma

Clinical trial NCT04735861 · COMPLETED

Trial details

NCT number: NCT04735861
Sponsor: Tongji Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Clear Cell Carcinoma

Start date: 2021-04-07
Primary completion: 2024-07-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.